Products

GEM® Premier 7000 with iQM3

Preanalytical errors can impact point-of-care testing. What might you be missing?

Hemolysis, the #1 source of preanalytical error¹, while prevalent throughout the hospital, is often unrecognized. This can negatively impact potassium (K⁺) results and patient care.²For the first time integrated on a blood gas system, the GEM Premier 7000 with iQM3 detects and flags hemolysis, in just 45 seconds.¹¹

A breakthrough in blood gas testing.

watch how whole blood hemolysis detection is possible

Hemolysis is the #1 source of preanalytical error¹

Preanalytical errors can affect the integrity of results in blood samples tested at the point of care (POC). Hemolysis accounts for up to 70% of all preanalytical errors and, while prevalent throughout the hospital, is often unrecognized. This can negatively impact potassium (K⁺) results and patient care.²

In vitro hemolysis can lead to:

Inappropriate patient management^3,6,7
Decreased patient satisfaction^6,8
Inefficient staff/nursing time^5,7,8
Increased costs^5,6,8

Hemolysis is prevalent throughout the hospital, and often unrecognized

Percentages indicate proportion of samples that are hemolyzed in each clinical setting

Illustration of areas of a hospital where hemolysis is prevalent: NICU, ICU, OR, ED, and LAB

ICU-Intensive Care Unit; NICU–Neonatal Intensive Care Unit; OR–Operating Room; ED-Emergency Department

A breakthrough in blood gas testing: hemolysis detection

In a transformative step toward enhancing patient outcomes in acute care, GEM Premier 7000 with iQM3 provides lab-quality detection of hemolysis, in whole blood.

Informs and expedites critical decision-making^3,6,12–16

Now with hemolysis detection, iQM3 ensures sample quality across the most common preanalytical errors (e.g., hemolysis, clots, bubbles). GEM Premier 7000 detects hemolysis in 45 seconds¹¹ helping inform appropriate patient management decisions.

GEM Premier 7000 with iQM3 analyzer showing the screen with hemolysis flag

How is whole blood hemolysis detection possible?

GEM Premier 7000 with iQM3 utilizes patented technology for hemolysis detection. Based on a photometric measurement of whole blood, the hemolysis module includes:

Acoustofluidic flow cell for plasma separation and hemolysis detection
Optical detector and LED light source to illuminate the optical flow cell for absorbance calculation at each wavelength

HIGHLIGHTS

iQM3 ensures sample quality across the most common preanalytical errors, detects hemolysis in 45 seconds¹¹
All-in-one GEM PAK cartridge automates labor- and skill-intensive processes
GEMweb® Plus 500 Custom Connectivity simplifies control and compliance, enabling continuous quality improvement

GEM PAK: advanced simplicity at the POC

Automates the most labor- and skill-intensive processes for improved productivity and cost-efficiency
Self-contained and multi-use, limiting operator biohazard and infection exposure
Room-temperature storage; no refrigeration required
Replaced every 31 days—only 12 GEM PAKs/year/analyzer**
No hands-on troubleshooting or corrective actions required
Variety of menu and test-volume configurations

Menu and PAK configurations

FLEXIBLE GEM PAK CUSTOMIZATION

Measured Analytes
pH, pCO₂, pO₂, Na⁺, K⁺, Cl^–, Ca⁺⁺, Glu, Lac, Hct, tBili, tHb, O₂Hb, COHb, MetHb, HHb, sO₂^‡
Derived (Calculated) Parameters
BE(B), BE(ecf), tHb(c), Ca⁺⁺ (7.4), Anion gap (AG), P/F ratio, pAO₂, CaO₂, CvO₂, p₅₀, O₂cap, sO₂(c), O₂ct, HCO₃ – std, TCO₂, HCO₃ – (actual), A-aDO₂, paO₂/pAO₂, RI, CcO₂, a-vDO₂, Q_sp/Q_t (est), Q_sp/Q_t, Hct(c), OI, Osm
Test volumes
75, 100, 150, 300, 450, 600**
Menu options:
Blood Gas, Hct, tHb, O₂Hb, HHb, COHb, MetHb, sO₂, tBili***
Blood Gas, Electrolytes, Hct, tHb, O₂Hb, HHb, COHb, MetHb, sO₂, tBili***
Blood Gas, Electrolytes, Glu, Lac, Hct, tHb, O₂Hb, HHb, COHb, MetHb, sO₂, tBili***

^{** 31-day onboard use-life, except 600-test PAK which has 21-days.}
^{*** PAKs available with or without tBili.}
^{ꭞ sO}_²^{= O}_²^Hb/O_²^Hb+HHb

REQUEST MORE INFORMATION

Lippi G, von Meyer A, Cadamuro J, Simundic A-M. Blood sample quality. Diagnosis. 2018;6(1):25–31. doi:10.1515/dx-2018-0018.
Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132.
O’Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis or sample contamination on patient care and outcomes in point-of-care testing: a retrospective study. J Appl Lab Med. 2020;5(2):332-341. doi:10.1093/jalm/jfz020.
Tóth J, Oláh AV, Petercsák T, Kovács T, Kappelmayer J. Detection of haemolysis, a frequent preanalytical problem in the serum of newborns and adults. eJIFCC. 2020Mar;31(1):6-14. PMID: 32256284; PMCID: PMC7109500.
Phelan MP, Ramos C, Walker LE, et al. The hidden cost of hemolyzed blood samples in the emergency department. J Appl Lab Med. 2021;6(6):1607–1610. doi:10.1093/jalm/jfab035.
Phelan MP, Hustey FM, Good DM, Reineks EZ. Seeing red: blood sample hemolysis is associated with prolonged emergency department throughput. J Appl Lab Med. 2020;5(4):732–737. doi:10.1093/jalm/jfaa073.
Wilson M, Adelman S, Maitre JB, et al. Accuracy of hemolyzed potassium levels in the emergency department. West J Emerg Med. 2020;21(6):272–275. doi:10.5811/westjem.2020.8.46812.
Milutinović D, Andrijević I, Ličina M, Andrijević L. Confidence level in venipuncture and knowledge on causes of in vitro hemolysis among healthcare professionals. Biochem Med. 2015;25(3):401–409. doi:10.11613/BM.2015.040.
Nichols JH, Apple FS. Prevalence of hemolyzed results in acute care settings. J Appl Lab Med. 2023;8:431-434. doi:10.1093/jalm/jfac141
Khedr S, Blake V, Erdogan E. Neonatal unit hemolysis rates from an academic medical center: A quality improvement project. Arch Path Lab. 2016;140(6):502-503. doi:10.5858/arpa.2015-0252-le
Werfen. GEM Premier 7000 with iQM3 Operators Manual. P/N 00000026407. Rev 00. Aug 2023.
Dietzen DJ, Jackups R, Zaydman MA. Clinical implications of inaccurate potassium determination in hemolyzed pediatric blood specimens. Clin Chim Acta. 2024;15(557):117862. doi:10.1016/j.cca.2024.117862.
Wu AHB, Peacock WF. Potential medical impact of unrecognized in vitro hypokalemia due to hemolysis: a case series. Clin Chem Lab Med. 2024;aop:1–5. https://doi.org/10.1515/cclm-2024-0351.
17. Azman WNW, Omar J, Koon TS, Ismai TST. Hemolyzed specimens: major challenge for identifying and rejecting specimens in clinical laboratories. Oman Med J. 2019;34(2):94–98.
18. Möckel M, Luppa PB. Why hemolysis detection should be an integral part of any near-patient blood gas analysis. J Lab Med. 2021;45(4-5):193–195. https://doi.org/10.1515/labmed-2021-0076.
Nigro M, Valli G, Marchionne ML, et al. Is there a risk of misinterpretation of potassium concentration from undetectable hemolysis using a POCT blood gas analyzer in the emergency department? Medicina. 2023;59(66):1–11. https://doi.org/10.3390/medicina59010066.